ANDA 217704, held by Nexus. Potassium Chloride.
As of Nov 15, 2026, ANDA 217704 (Potassium Chloride), held by Nexus, was first approved by FDA on Aug 14, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 14, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Potassium Chloride2MEQ/ML ยท injectable;injection | Potassium Chloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
